Seattle, WA, United States of America

Lynn Bonham

USPTO Granted Patents = 4 

Average Co-Inventor Count = 6.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2000-2009

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Lynn Bonham: Innovator in Cancer Treatment

Introduction

Lynn Bonham is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of new therapeutic methods. With a total of 4 patents, her work focuses on the inhibition of specific enzymes that play a role in cancer progression.

Latest Patents

One of her latest patents is titled "LPAAT-β inhibitors and uses thereof." This invention relates to triazines and their application in inhibiting lysophosphatidic acid acyltransferase β (LPAAT-β) activity. The invention further outlines methods for treating cancer using these triazines, as well as techniques for screening LPAAT-β activity. This groundbreaking work has the potential to advance cancer treatment significantly.

Career Highlights

Throughout her career, Lynn has worked with notable organizations such as Cell Therapeutics, Inc. and the Fred Hutchinson Cancer Center. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to cutting-edge research.

Collaborations

Lynn has collaborated with esteemed colleagues, including Baoqing Gong and John E Tulinsky. These partnerships have enriched her research and expanded the impact of her inventions.

Conclusion

Lynn Bonham's innovative work in cancer treatment exemplifies the vital role of inventors in advancing medical science. Her patents and collaborations highlight her commitment to improving patient outcomes through targeted therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…